Pharmafit Provence
Official logo Alnylam Pharmaceuticals

Biopharma

Alnylam Pharmaceuticals

RNA interference medicines

Browse associated productsOfficial website

About Alnylam Pharmaceuticals

Alnylam is a biopharmaceutical company specialising in medicines based on RNA interference.

French resources cover hereditary transthyretin-mediated amyloidosis, acute hepatic porphyria and primary hyperoxaluria type 1. The company explains its scientific platform and the use of RNA interference in medicine development.

Official sources

Information checked 10 November 2026

Logo source

Associated catalogue products

1 reference

These products are linked to this organisation in the catalogue as a laboratory or supplier. Refer to each product page for its documented manufacturer or operator. Purchasing terms and ordering are available through your professional account.

Your professional shop

Open the shop to sign in, view the terms available to your account and place your order.

Open the shop